Fulcrum Therapeutics to Participate at Upcoming November Investor Conferences

CAMBRIDGE, Mass., Nov. 09, 2023 (GLOBE NEWSWIRE) — Fulcrum Therapeutics, Inc.® (Nasdaq: FULC), a clinical-stage biopharmaceutical company focused on developing small molecules to improve the lives of patients with genetically defined rare diseases, today announced that management will participate in the following upcoming investor conferences:

  • Stifel Healthcare Conference
    Tuesday, November 14, 2023 at 3:00 p.m. ET (Fireside Chat)
  • Piper Sandler 35th Annual Healthcare Conference
    Thursday November 30, 2023 at 11:00 a.m. ET (Fireside Chat)

A live webcast of each presentation will be available by visiting the “Events and Presentations” section of Fulcrum Therapeutics’ website at https://ir.fulcrumtx.com/events-and-presentations. A replay of the webcasts will be available on Fulcrum Therapeutics’ website for 90 days following each presentation.

About Fulcrum Therapeutics
Fulcrum Therapeutics is a clinical-stage biopharmaceutical company focused on developing small molecules to improve the lives of patients with genetically defined rare diseases in areas of high unmet medical need. Fulcrum’s two lead programs in clinical development are losmapimod, a small molecule in development for the treatment of facioscapulohumeral muscular dystrophy (FSHD), and pociredir (formerly known as FTX-6058), a small molecule designed to increase expression of fetal hemoglobin and in development for the treatment of sickle cell disease (SCD) and other hemoglobinopathies. Fulcrum uses proprietary technology to identify drug targets that can modulate gene expression to treat the known root cause of gene mis-expression. For more information, visit www.fulcrumtx.com and follow us on Twitter/X (@FulcrumTx) and LinkedIn.

Contact:

Chris Calabrese
LifeSci Advisors, LLC
ccalabrese@lifesciadvisors.com
917-680-5608

Staff

Recent Posts

Omni-Biotic US Introduces Omni-Biotic Power: A New Performance Probiotic

Omni-Biotic, an award-winning leader in probiotic supplements from Austria, is launching Omni-Biotic Power in the…

3 hours ago

1 in Every 10 Children in South Sudan Die Before They Turn 5; Here’s How To Help

NORTHAMPTON, MA / ACCESSWIRE / June 10, 2024 / Akoi Dau Pawol was born and…

3 hours ago

Quest Diagnostics Elects Robert B. Carter, CIO of FedEx Corporation, to Board of Directors

SECAUCUS, NJ / ACCESSWIRE / June 10, 2024 / Quest Diagnostics (NYSE:DGX), a leading provider…

3 hours ago

Nava Health Announces Lease Signing for First New York Location

COLUMBIA, MD / ACCESSWIRE / June 10, 2024 / Nava Health, a leader in longevity,…

3 hours ago

Harmonic, Backed by Robinhood CEO Vlad Tenev, Announces Development of Mathematical Superintelligence Platform

AI Model Designed to Guarantee Accuracy & Avoid HallucinationsPALO ALTO, Calif.--(BUSINESS WIRE)--Harmonic, an artificial intelligence…

6 hours ago